PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 42 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,000 | -20.0% | 11,200 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | +15.4% | 11,200 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | -50.0% | 11,200 | 0.0% | 0.00% | – |
| Q4 2019 | $26,000 | +188.9% | 11,200 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -50.0% | 11,200 | -38.8% | 0.00% | – |
| Q2 2019 | $18,000 | -97.0% | 18,300 | -96.1% | 0.00% | – |
| Q1 2019 | $594,000 | -38.8% | 471,360 | +57.5% | 0.00% | – |
| Q4 2018 | $970,000 | +49.9% | 299,363 | +11.1% | 0.00% | – |
| Q3 2018 | $647,000 | +10.0% | 269,567 | +28.2% | 0.00% | – |
| Q2 2018 | $588,000 | +833.3% | 210,200 | +1468.7% | 0.00% | – |
| Q1 2018 | $63,000 | -91.7% | 13,400 | -86.2% | 0.00% | – |
| Q1 2017 | $760,000 | -28.2% | 97,167 | +12.4% | 0.00% | – |
| Q4 2016 | $1,059,000 | -28.9% | 86,471 | -9.6% | 0.00% | – |
| Q3 2016 | $1,490,000 | +34.4% | 95,617 | +4.7% | 0.00% | – |
| Q2 2016 | $1,109,000 | – | 91,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 848,610 | $2,749,000 | 2.00% |
| GREAT POINT PARTNERS LLC | 3,045,423 | $9,867,000 | 1.25% |
| NEA Management Company, LLC | 5,556,778 | $18,004,000 | 0.71% |
| VHCP Management II, LLC | 501,390 | $1,625,000 | 0.70% |
| SECTORAL ASSET MANAGEMENT INC | 1,581,728 | $5,125,000 | 0.70% |
| HARBOURVEST PARTNERS LLC | 440,627 | $1,428,000 | 0.68% |
| EAM Investors, LLC | 596,871 | $1,934,000 | 0.52% |
| EAM Global Investors LLC | 252,778 | $819,000 | 0.45% |
| Avoro Capital Advisors LLC | 1,300,000 | $4,212,000 | 0.25% |
| Ghost Tree Capital, LLC | 190,000 | $616,000 | 0.22% |